Skip to content

Defeat Cancer by Detecting it Early

EarlyDiagnostics (EarlyDx) is devoted to providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.


Big Data for Better Diagnosis

We have developed a blood test, CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. In addition, we developed a One-Stop Shop bioinformatics solution, EarlyDx-Cloud, to help many diagnostic companies offer liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring.

how it works

The Technology behind Cancer Detection

Discover our experimental and computational innovations.

CancerRadar is a blood test, which is highly sensitive in detecting a trace amount of tumor DNA in cell-free DNAs.

Cloud Platform

EarlyDx-Cloud is a cloud-based platform for integrative bioinformatics analysis.


Our technologies are empowered by Innovation.

Our Team

Our Experts Are Waiting For You

We bring the right people together to challenge established thinking and drive transformation.

Latest News

Read the latest news and blog posts from EarlyDx.

April 2021

Co-founder Jasmine Zhou to Report EarlyDx’s CancerRadar Technology and Clinical Data in Oral Presentation at AACR Annual Meeting 2021 on April 10, 2021.

May 2020

EarlyDx Awarded an NIH SBIR Phase I Grant for Assay Development.